EATG » Tuberculosis

Tuberculosis

Bosnia and Herzegovina must continue the fight against HIV/AIDS, TB without Global Fund’s aid

Bosnia and Herzegovina (BiH) can remain a country with the lowest HIV rate in Europe and sustained reduction of tuberculosis levels only if full implementation of the transition from international…

New confidential text shows draft deal on UN TB Declaration

A newly agreed draft text of the United Nations political declaration on tuberculosis was released to governments today, affirming the use of flexibilities in international trade rules on intellectual property,…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 341 of the ‘Global Fund Observer.’ The newsletter includes articles…

UN TB negotiations: What is at stake?

With negotiations over the final language of a United Nations high level declaration on ending tuberculosis still ongoing, the stakes are high as different TB stakeholders await the outcome. The…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 340 of the ‘Global Fund Observer.’ The newsletter includes articles…

SimpliciTB clinical trial launched with first patients in Tbilisi, Georgia

New pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multidrug-resistant tuberculosis NEW YORK, NY (August 28, 2018)—TB Alliance has initiated a pivotal clinical trial, SimpliciTB…

Handbook on TB laboratory diagnostic methods in the European Union – updated 2018

The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols…

WHO announces landmark changes in MDR-TB treatment regimens

17 August 2018, Geneva - Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant tuberculosis (MDR-TB)* are expected, following key changes in MDR-TB treatment announced by…

Study demonstrates mortality benefit of Xpert TB assay in HIV patients

Patients newly diagnosed with advanced HIV in Malawi who were screened for tuberculosis with the Xpert MTB/RIF assay had significantly lower rates of 12-month, all-cause mortality than patients who were…

Open letter: UN General Assembly High Level Meeting on the fight against Tuberculosis

Few weeks before the UN General Assembly High Level Meeting on the fight against Tuberculosis, the EATG issues an open letter: 'As negotiations on the final declaration are now being…

1 3 4 5 6 7 48